Host transcript accumulation during lytic KSHV infection reveals several classes of host responses

PLoS ONE

Volumn 2, Issue 8, 2007, Pages

  Chandriani, Sanjay ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXONUCLEASE; MESSENGER RNA; SHUT OFF AND EXONUCLEASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC ALGORITHM; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; MICROARRAY ANALYSIS; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; CELL CULTURE; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

CELLS, CULTURED; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 41049098677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000811     Document Type: Article

References (46)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86: 1276-1280.
4. Moore PS, Chang Y (199A) Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332: 1181-1185.
5. Schulz TF (1999) Epidemiology of Kaposi's aarcoma-associated herpesvirus/ human herpesvirus 8. Adv Cancer Res 76: 121-160.
6. Sarid R, Wiezorek JS, Moore PS, Chang Y (1999) Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 73: 1438-1446.
7. Zhong W, Wang H, Herndier B, Ganem D (1996) Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 93: 6641-6646.
8. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309-8315.
9. Renne R, Lagunoff M, Zhong W, Ganem D (1996) The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70: 8151-8154.
10. Bechtel JT, Liang Y, Hvidding J, Ganem D (2003) Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 77: 6474-6481.
11. Sun F, Lin SF, Gradoville 1, Yuan Y, Zhu F, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866-10871.
12. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, et al. (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2: 342-346.
13. Ganem D (2007) Kaposi's sarcoma-associated herpesvirus. In: Knipe D, Howley P, eds (2007) Fields' Virology. 5th ed. Philadelphia. Lippincott, Williams & Wilkins. pp 2847-2888.
14. Lukac: DM, Renne R, Kirshner JR, Ganem D (1998) Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252: 304-312.
15. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, et al. (1997) Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 71: 314-324.
16. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa. (CSL), the target of die Notch signaling pathway. Genes Dev 16: 1977-1989.
17. Wang SE, Wu FY, Fujimuro M, Zong J, Hayward SD, et al. (2003) Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J Virol, 77: 600-623.
18. Wang SE, Wu FY, Yu Y, Hayward GS (2003) CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J Virol 77: 9590-9612.
19. Gwack Y, Hwang S, Lim C, Won YS, Lee CH, et al. (2002) Kaposi's Sarcoma-associated herpesvirus open reading frame: 50 stimulates the transcriptional activity of STAT3. J Biol Chem 277: 6438-6442.
20. Kirshner JR, Lukac DM, Chang J, Ganem D (2000) Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 74: 3586-3597.
21. Wang S, Liu S, Wu MH, Geng Y, Wood C (2001) Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol 75: 11961-11973.
22. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, et al. (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340: 1063-1070.
23. Nicholas J (2005) Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25: 373-383.
24. Arvanitakis L, Geras-Raaka E,Varma A, Genhengorn MC, Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347-350.
25. Bais C, Santomasso B, Coso O, Arvanitakis I, Raaka EG, et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvinis is a viral oncogene and angiogenesis activator. Nature 391: 86-89.
26. Yang TY, Chen SC, Leach MW, Manfra D, Horney B, et al. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445-454.
27. Glaunsinger B, Ganem D (2004) Lyric KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13: 713-723.
28. Glaunsinger B, Canem D (2004) Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J Exp Med 200: 391-398.
29. Venetsanakcs E, Mirza A, Fanton C, Romanov SR, Tisty T, et al. (2002) Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 273: 21-33.
30. de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software. Bioinformatics 20: 1453-1454.
31. Saldanha AJ (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
32. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29: 246-254.
33. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, et al. (1995) Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1: 1274-1278.
34. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, et al. (1997) Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71: 715-719.
35. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, et al. (1997) Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and Affican Kaposi's sarcoma. Int J Cancer, 72: 68-71.
36. van de Peppel J, Kemmeren P, van Bakel H, Radonjic M, van Leenen D, et al. (2003) Monitoring global messenger RNA changes in externally controlled microarray experiments. EMBO Rep 4: 387-393.
37. Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32 Suppl: 496-501.
38. Li M, Damania B, Alvarez X, Ogryzko V, Ozato K, et al. (2000) Inhibition of p300 histone acetyltransferase by viral interreron regulatory factor. Mol Cell Biol 20: 8254-8263.
39. Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, et al. (2001) HHV-8 encoded vIRF-I represses die intff&ron antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20: 800-811.
40. Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ (2006) Inhibidon of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80: 3092-3097.
41. Zhu FX, King SM, Smith EJ, Levy DE, Yuan Y (2002) A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A 99: 5573-5578.
42. Joo CH, Shin YC, Gack M, Wu L, Levy D, et al. (2007) Inhibition of interferon regulatory factor 7 (IRF)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRFF homolog vIRF3. J Virol 81: 8282-8292.
43. Alexander WS, Hilton DJ (2004) The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Iummunol 22: 503-529.
44. Barreau C, Paillard L, Osborne HB (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33: 7138-7150.
45. McCormick C, Ganem D (2005) The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytoldne mRNAs. Science 307: 739-741.
46. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2: 28-36.